Kuros Biosciences AG
CSBTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,920 | -$13,347 | -$15,991 | -$9,554 |
| Dep. & Amort. | $2,636 | $2,752 | $2,834 | $2,880 |
| Deferred Tax | $0 | $0 | $5,112 | $130 |
| Stock-Based Comp. | $5,127 | $917 | $1,030 | $389 |
| Change in WC | -$3,305 | -$3,649 | -$1,266 | -$187 |
| Other Non-Cash | $2,602 | $4,483 | $933 | $889 |
| Operating Cash Flow | $3,140 | -$8,844 | -$7,348 | -$5,453 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,095 | -$317 | -$400 | -$374 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$17 | -$9 | $0 | $0 |
| Investing Cash Flow | -$1,112 | -$326 | -$400 | -$374 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$604 | -$672 | -$343 | -$322 |
| Stock Issued | $1,941 | $501 | $6,000 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$2,433 | $6,400 |
| Financing Cash Flow | $1,337 | -$171 | $3,224 | $6,078 |
| Forex Effect | $448 | -$516 | -$34 | -$10 |
| Net Chg. in Cash | $3,813 | -$9,857 | -$4,558 | $241 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,208 | $24,065 | $28,623 | $28,388 |
| End Cash | $18,021 | $14,208 | $24,065 | $28,629 |
| Free Cash Flow | $2,028 | -$9,170 | -$7,748 | -$5,827 |